- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02210377
A Preliminary Randomized Study of Tianjiu (Auto-moxibustion) Effects in Patients With Intradialytic Hypotension
January 28, 2016 updated by: Ming-Yen Tsai, Chang Gung Memorial Hospital
Department of Traditional Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung
Intradialytic hypotension (IDH) is a most frequent complication of hemodialysis (HD) and may contribute to cardiovascular events and high mortality.
The etiology of IDH is multifactorial; therefore, it remains a challenging problem in the management of HD patients.
Because moxibustion (MO) at specific points can influences hemodynamics, we hypothesize that Tianjiu (auto-MO) at the traditionally used meridian points will reduce the severity of hypotension in patients who undergo HD.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
In this clinical trial, 45 patients had IDH were divided randomly into two (auto-MO therapy and control) groups for 4 weeks.
In the Tianjiu (auto-MO) group, the patients were applied at 3 points (Conception Vessel 4, and Kidney 1) for 3-4 h during HD sessions.
All number of episodes complicated by symptomatic IDH during HD sessions and the number of IDH-related nursing interventions (Trendelenburg position, manual reduction of ultrafiltration rate, infusion of isotonic saline or hypertonic fluid, lowering of dialysate temperature) in a session were recorded.
Pre- and post-dialysis systolic and diastolic BP, pre- and post-dialysis body weights, interdialytic weight gain, percentage of target ultrafiltration achieved, patient's subjective assessment of the degree of fatigue after dialysis (scale from 0 to 10; 0, not at all, 10, extremely) and recovery time from fatigue after dialysis were measured at the 0, 2nd, 4th and 6th week.
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kaohsiung, Taiwan, 83301
- Recruiting
- Kaohsiung Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subjects enrolled in the study were patients undergo regular hemodialysis, ranging from 20-75 years of age, at nephrologic clinic in KCGMH. These patients have experienced > 3 episodes of intradialytic hypotension in recent two months.
Exclusion Criteria:
- (1)confounding diseases such as sepsis, cancer, decompensated liver cirrhosis, respiratory failure, and heart failure(NYHA>3), (2) disturbed consciousness, (3) pregnancy, (4) can't tolerate the heat and allergy to automoxibustion,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tianjiu (auto-moxibustion)
The participants in the Tianjiu group will be treated with Chinese herbal patches at acupoints on the abdomen and plantar, three times per week, for 4 hours each time during HD.
|
After randomization, patients in Tianjiu and placebo (non-Tianjiu) groups will receive 12 sessions of treatment over a 4-week treatment period.The format of the Tianjiu intervention will be the same as in the treatment group.
Participants will be instructed to lie supine before their HD session, and then the bilateral KI1 and CV4
Other Names:
|
|
Placebo Comparator: Non-Tianjiu (Non auto-MO)
The participants in the control group will be given placebo patches (brown clay patches) on the same sites.
|
The format of the placebo (clay) intervention will be the same as in the treatment group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The % of target ultrafiltration achieved
Time Frame: 1 year
|
The actual ultrafiltration volume divided by the target ultrafiltration volume
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The frequency of IDH episodes and number of nursing interventions during HD sessions
Time Frame: 1 year
|
The number of IDH record and related nursing intervention during each H/D session
|
1 year
|
|
patient's participative assessment of the degree of fatigue after dialysis (scale from 0-10)
Time Frame: 1 year
|
The improvement of subjective symptom
|
1 year
|
|
Patients' recovery time from fatigue after dialysis
Time Frame: 1 year
|
Recovery time is recorded within minutes, when arriving home, at bed time, the next morning, by next HD
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Anticipated)
June 1, 2016
Study Completion (Anticipated)
June 1, 2016
Study Registration Dates
First Submitted
August 3, 2014
First Submitted That Met QC Criteria
August 4, 2014
First Posted (Estimate)
August 6, 2014
Study Record Updates
Last Update Posted (Estimate)
February 1, 2016
Last Update Submitted That Met QC Criteria
January 28, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Chang Gung IRB 102-4749A3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Depending on the progress to decide.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intradialytic Hypotension
-
Chang Gung Memorial HospitalNot yet recruitingEnd Stage Renal Disease on Dialysis | Intradialytic HypotensionTaiwan
-
Chang Gung Memorial HospitalNot yet recruiting
-
China Medical University, TaiwanChang Gung Memorial Hospital; Taipei Veterans General Hospital, TaiwanCompletedIntradialytic Hypotension
-
Assaf-Harofeh Medical CenterCompletedIntradialytic Hypotension | ImmersionIsrael
-
Centre Hospitalier de BethuneCHU de LilleRecruiting
-
Ain Shams UniversityActive, not recruitingIntradialytic HypotensionEgypt
-
NimedicalUnknownIntradialytic Hypotension
-
Global Monitors, Inc.University of VirginiaCompleted
-
Beijing University of Chinese MedicineBeijing First Hospital of integrated Chinese and Western Medicine; Dongfang... and other collaboratorsUnknownIntradialytic HypotensionChina
-
Danish State HospitalCompleted